2023 10-K – PMV Pharmaceuticals Inc.

10-K

from 10-K 133 pages 10-K

02/29/24

EX-10.15

from 10-K 5 pages PMV Pharmaceuticals, Inc. Outside Director Compensation Policy

02/29/24

EX-10.20

from 10-K 10 pages PMV Pharmaceuticals, Inc. Consulting Agreement

02/29/24

EX-10.21

from 10-K 4 pages January 05, 2024 via Email Dear Leila, This Letter Memorializes the Terms and Conditions for Your Separation From Employment as the Chief Medical Officer for PMV Pharma (The "Company"), Effective as of the Date Hereof (“Separation Date”). 1. Consideration. in Consideration of Your Execution of This Letter and Your Fulfillment of All of Its Terms and Conditions, Company Shall Make the Following Consideration Payments to You: A

02/29/24

EX-10.22

from 10-K 4 pages January 05, 2024 Michael Carulli C/O PMV Pharmaceuticals, Inc. Dear Mike,

02/29/24

EX-10.23

from 10-K 9 pages PMV Pharmaceuticals, Inc. Consulting Agreement

02/29/24

EX-10.23

from 10-K Pdf Courtesy Copy

02/29/24

EX-10.24

from 10-K 4 pages Change in Control and Severance Policy (The "Policy") Amended and Restated Participation Agreement

02/29/24

EX-23.1

from 10-K 2 pages Consent of expert or counsel

02/29/24

EX-31.1

from 10-K 3 pages Management certification of annual or quarterly disclosure

02/29/24

EX-31.2

from 10-K 3 pages Management certification of annual or quarterly disclosure

02/29/24

EX-32.1

from 10-K 2 pages Management certification of financial report

02/29/24

EX-32.2

from 10-K 2 pages Management certification of financial report

02/29/24

EX-97.1

from 10-K 6 pages

02/29/24

Exhibits

Graphics & Data Files

External Links